Companies · Biotechnology

Mi-Helper, Inc.

BALTIMORE · Biotechnology

Diligence memoA one-page analyst read on Mi-Helper, Inc. — recommendation, valuation, rhythm, risks.→
$4.0M
Total raised · real
1
Rounds
—
Latest step-up
Top 61%
Sector rank · raised
Seed
Latest stage · inferred · Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Mi-Helper, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 3.58× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era.
Dormant
  • Last raise 3.7 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

Mi-Helper, Inc. is one of 4293 Biotechnology companies tracked from BALTIMORE. By capital raised it ranks mid-pack (ahead of 40% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2021
Year incorporated
2022-10-03
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2022-10-03 Raised $4.0M (real) Modeled valuation $51M (est)$4.0M$51MSeed2022

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$4.0M · 2022

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$50.9M
Base estimate est.
$2.9M
Conservative case
$217.3M
Upside case
$20.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
32%
Survival probability
14% low · 50% high
1.74×/yr
Annual markup
2.28×/yr upside case
3.8 yr
Elapsed time used
3.8 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
—
Avg between rounds
—
Capital velocity
4.0 yr
On record since
2022
First round
1
Rounds on file
How it compares to the market

Benchmarked against 4293 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages)▼ 0.6× of median
This company$4.0M
Sector median$7.2M
Latest round — vs other Seed rounds in sector (real $, this stage)▲ 2.3× above median
This company$4.0M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages)▼ 0.8× of median
This company$50.9M
Sector median$64.2M

Raised more than 40% of sector peers (real $). Modeled value above 45% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #8 of 207.

This companyCohort peer
$10.0M$100.0M$1.0M$10.0MCapital raised (log)Mesentech Inc. · Seed Raised $3.9M · modeled $65.7M (est)Marlinspike Therapeutics, Inc. · Seed Raised $3.5M · modeled $64.4M (est)Microbial Machines, Inc. · Seed Raised $3.9M · modeled $63.7M (est)Pearl Diagnostics, Inc. · Seed Raised $3.5M · modeled $62.9M (est)Crossfire Medical Inc · Seed Raised $3.0M · modeled $57.5M (est)Design Pharmaceuticals, Inc. · Seed Raised $3.0M · modeled $57.0M (est)Tekv Holdings LLC · Seed Raised $4.0M · modeled $55.5M (est)Thelium Therapeutics Inc. · Seed Raised $3.1M · modeled $50.7M (est)Turtle Health, Inc. · Seed Raised $2.7M · modeled $49.1M (est)Accufix Holdings, Inc. · Seed Raised $4.2M · modeled $46.7M (est)Kyttaro Ltd · Seed Raised $5.2M · modeled $45.5M (est)Mi-Helper, Inc. (this company) Raised $4.0M · modeled $50.9M (est)Mi-Helper, Inc.
CompanyStageRaised · realValue · estvs peer med.
Mesentech Inc.Seed$3.9M$65.7M4.61×
Marlinspike Therapeutics, Inc.Seed$3.5M$64.4M4.52×
Microbial Machines, Inc.Seed$3.9M$63.7M4.47×
Pearl Diagnostics, Inc.Seed$3.5M$62.9M4.41×
Crossfire Medical IncSeed$3.0M$57.5M4.04×
Design Pharmaceuticals, Inc.Seed$3.0M$57.0M4.00×
Tekv Holdings LLCSeed$4.0M$55.5M3.89×
Mi-Helper, Inc. this companySeed$4.0M$50.9M3.58×
Thelium Therapeutics Inc.Seed$3.1M$50.7M3.56×
Turtle Health, Inc.Seed$2.7M$49.1M3.45×
Accufix Holdings, Inc.Seed$4.2M$46.7M3.28×
Kyttaro LtdSeed$5.2M$45.5M3.20×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$4.0M2022-10-03$20.0M$50.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$4.0M2022-10-03
    • First recorded raise — entered as Seed.
    • 3 investors on this round.
Intelligence
—
Modeled next raise
$6.4M
Modeled next size est.range $4.2M–$10.2M
—
Last step-up
—
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Brian E. Lipford——2022-10
Eileen E. O'Rourke——2022-10
Harikrishna E. Tandri——2022-10
Keith E. Sullivan——2022-10
Steven E. Schaefer——2022-10
Registry & provenance

Mi-Helper, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1949966
SEC CIK
2021
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Tekv Holdings LLCBiotechnologySeed$4.0M$55.5Msame sector · same stage
Accufix Holdings, Inc.BiotechnologySeed$4.2M$46.7Msame sector · same stage
CannTrust Inc.BiotechnologySeed$3.8M$44.4Msame sector · same stage
KeriCure IncBiotechnologySeed$3.8M$44.2Msame sector · same stage
VuEssence, Inc.BiotechnologySeed$3.8M$46.6Msame sector · same stage
Tangible Science, Inc. (fka Tangible Science, LLC)BiotechnologySeed$4.3M$59.9Msame sector · same stage
Intuitive Biosciences, Inc.BiotechnologySeed$3.6M$54.3Msame sector · same stage
Figure 8 Surgical Inc.BiotechnologySeed$3.6M$55.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Mimerigen, Inc.BiotechnologyPre-Seed$472K88%
Arbor Biotechnologies, Inc.BiotechnologySeries D+$5.7B86%
Access Bio, Inc.BiotechnologySeries A$301.1M85%
Metagenomi Technologies, LLCBiotechnologySeries D+$1.7B85%
Genome Insight, Inc.BiotechnologySeries A$39.9M84%
SMSbiotech, Inc.BiotechnologySeries B$64.6M84%
Judo Bio Inc.BiotechnologySeries B$172.2M84%
Serimmune Inc.BiotechnologySeries A$83.5M84%
Frequently asked
How much funding has Mi-Helper, Inc. raised?
Mi-Helper, Inc. has raised approximately $4.0M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Mi-Helper, Inc.'s estimated valuation?
Provath's modeled valuation for Mi-Helper, Inc. is approximately $50.9M (modeled range $2.9M–$217.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Mi-Helper, Inc. at?
Mi-Helper, Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Mon Oct 03.
What does Mi-Helper, Inc. do and where is it based?
Mi-Helper, Inc. operates in the Biotechnology sector, based in BALTIMORE.
Explore related

See where Mi-Helper, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Mi-Helper, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.